Data Management and Distribution Core
Document text
Principal Investigator: COULSON KGATHI Organization: HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH Fiscal Year: 2024 Award: $49,352 Funding agency: Eunice Kennedy Shriver National Institute of Child Health and Human Development Project Summary/Abstract, Data Management and Distribution Core (Core B) The proposed program project aims to close research gaps in antiretroviral treatment for pregnant women and infants living with HIV with four inter-related projects that will require data management and data sharing. The Data Management and Distribution Core will build on its long experience managing clinical and laboratory data at the Botswana-Harvard AIDS Institute Partnership to ensure successful support for all data aspects of this program. Three projects (Projects 1, 3, and 4) will require database creation, maintenance, and support for data collection and management. The Tsepamo Plus birth outcomes surveillance study (Project 1) will provide data for the Methodology Project (Project 2) and for Point-of-Care HIV Testing and Infant Treatment (Project 3). Project 3 will provide data for the Immune Control Study (Project 4). Projects 3 and 4 require systems for receiving and storing laboratory data from the Botswana-Harvard HIV Reference Laboratory. The Data Core will oversee an active and efficient system of cross-talk between projects to facilitate achievement of the P01 program goals internally. In addition, the Data Core will be responsible for routine and external data distribution, and for data dissemination. Terms: <0-11 years old><2019-nCoV vaccine><AIDS><AIDS Virus><AIDS test><AIDS/HIV test><Achievement><Achievement Attainment><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Anti-Retroviral Agents><Bechuanaland><Birth><Botswana><COVID-19 vaccine><Child><Child Youth><Children (0-21)><Clinical Management><Collaborations><Data><Data Bases><Data Collection><Data Reporting><Data Set><Databases><Dedications><Ensure><Gestation><Goals><HIV><HIV test><HIV-1 test><HIV-2 test><Human Immunodeficiency Viruses><Human immunodeficiency virus test><Immune><Immunes><Infant><LAV-HTLV-III><Laboratories><Link><Lymphadenopathy-Associated Virus><Maintenance><Methodology><Mothers><Outcome><P01 Mechanism><P01 Program><Participant><Parturition><Patients><Pregnancy><Pregnant Women><Process><Program Project Grant><Program Research Project Grants><Quality Control><Research><Research Program Projects><Research Specimen><SARS-CoV-2 vaccine><SARS-coronavirus-2 vaccine><Services><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Specimen><Surveillance Program><System><Virus-HIV><anonymous data><anti-retroviral><antiretroviral therapy><antiretroviral treatment><coronavirus disease 2019 vaccine><coronavirus disease-19 vaccine><data anonymization><data base><data dissemination><data management><data representation><data representations><data sharing><distributed data><electronic data><expectant mother><expecting mother><experience><kids><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><point of care><pregnant mothers><programs><quality assurance><surveillance study><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine candidates against SARS-CoV-2><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID><youngster>